Cellectar Clinical Trial News
March 9, 2010
Cellectar Completes Enrollment In Phase I Clinical Trial of Lead Drug Candidate 131I-CLR1404 For The Treatment of Solid Malignancies

FDA Clears Cellectar's IND Application for Lead Drug Candidate
March 3, 2009
Cellectar's lead candidate¹³¹to Enter Clinical Trials.

Cellectar, Inc. Begins GMP Production
August 18, 2008
Radiopharmaceutical production facility to support clinical development for lead drug candidate and other molecules.



View Archives